Plasma levels of cGMP, a surrogate biomarker of clinical and experimental symptomatic HFrEF [24,30,32,33,34,35], were elevated approximately two-fold in DCM mice on a LSD, despite the reduction of ANP/BNP plasma levels. This evidence concerns the gene NPPA and familial dilated cardiomyopathy.